Annual Long Term Debt
$104.49 M
+$14.23 M+15.77%
31 December 2023
Summary:
CymaBay Therapeutics annual long term debt is currently $104.49 million, with the most recent change of +$14.23 million (+15.77%) on 31 December 2023. During the last 3 years, it has risen by +$53.47 million (+104.82%).CBAY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$104.49 M
+$396.00 K+0.38%
31 December 2023
Summary:
CymaBay Therapeutics quarterly long term debt is currently $104.49 million, with the most recent change of +$396.00 thousand (+0.38%) on 31 December 2023.CBAY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +104.8% | +104.8% |
| 5 y5 years | +5894.7% | +5894.7% |
CBAY Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | at high |
CymaBay Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $104.49 M(+15.8%) | $104.49 M(+0.4%) |
| Sept 2023 | - | $104.09 M(+4.9%) |
| June 2023 | - | $99.25 M(+4.9%) |
| Mar 2023 | - | $94.63 M(+4.8%) |
| Dec 2022 | $90.26 M(+76.9%) | $90.26 M(+4.5%) |
| Sept 2022 | - | $86.36 M(+4.4%) |
| June 2022 | - | $82.71 M(+4.4%) |
| Mar 2022 | - | $79.22 M(+55.3%) |
| Dec 2021 | $51.02 M(+3942.4%) | $51.02 M(+111.7%) |
| Sept 2021 | - | $24.10 M(+2339.6%) |
| June 2021 | - | $988.00 K(-12.3%) |
| Mar 2021 | - | $1.13 M(-10.7%) |
| Dec 2020 | $1.26 M(-27.6%) | $1.26 M(-9.1%) |
| Sept 2020 | - | $1.39 M(-8.1%) |
| June 2020 | - | $1.51 M(-7.3%) |
| Mar 2020 | - | $1.63 M(-6.5%) |
| Dec 2019 | $1.74 M | $1.74 M(-5.8%) |
| Sept 2019 | - | $1.85 M(-5.3%) |
| June 2019 | - | $1.95 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $2.05 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2018 | - | $2.14 M(-28.4%) |
| Dec 2017 | $2.99 M(-51.0%) | $2.99 M(-21.5%) |
| Sept 2017 | - | $3.81 M(-17.2%) |
| June 2017 | - | $4.60 M(-14.2%) |
| Mar 2017 | - | $5.36 M(-12.1%) |
| Dec 2016 | $6.10 M(-30.7%) | $6.10 M(-10.4%) |
| Sept 2016 | - | $6.81 M(-9.2%) |
| June 2016 | - | $7.50 M(-8.1%) |
| Mar 2016 | - | $8.16 M(-7.3%) |
| Dec 2015 | $8.80 M(+179.2%) | $8.80 M(-4.3%) |
| Sept 2015 | - | $9.20 M(+278.7%) |
| June 2015 | - | $2.43 M(-12.8%) |
| Mar 2015 | - | $2.78 M(-11.7%) |
| Dec 2014 | $3.15 M(-28.5%) | $3.15 M(-9.3%) |
| Sept 2014 | - | $3.48 M(-8.4%) |
| June 2014 | - | $3.79 M(-7.5%) |
| Mar 2014 | - | $4.10 M(-7.0%) |
| Dec 2013 | $4.41 M | $4.41 M |
FAQ
- What is CymaBay Therapeutics annual long term debt?
- What is the all time high annual long term debt for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for CymaBay Therapeutics?
What is CymaBay Therapeutics annual long term debt?
The current annual long term debt of CBAY is $104.49 M
What is the all time high annual long term debt for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual long term debt is $104.49 M
What is CymaBay Therapeutics quarterly long term debt?
The current quarterly long term debt of CBAY is $104.49 M
What is the all time high quarterly long term debt for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly long term debt is $104.49 M